NEXT vs. ADMA

Last updated Jun 4, 2026

NEXT (NextDecade Corporation) and ADMA (ADMA Biologics, Inc.) are both stocks. NEXT operates in Oil & Gas E&P (Energy), while ADMA operates in Biotechnology (Healthcare). Over the past 10 years, NEXT returned -1.63%/yr vs 0.37%/yr for ADMA. At a 0.15 correlation, their price movements are largely independent.

Performance

NEXT vs. ADMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NextDecade Corporation (NEXT) and ADMA Biologics, Inc. (ADMA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NEXT achieves a 60.15% return, which is significantly higher than ADMA's -57.46% return. Over the past 10 years, NEXT has underperformed ADMA with an annualized return of -1.63%, while ADMA has yielded a comparatively higher 0.37% annualized return.

NEXT

• 1D: 2.06%
• 1M: -0.94%
• YTD: 60.15%
• 6M: 37.91%
• 1Y: 2.68%
• 3Y*: 13.65%
• 5Y*: 28.17%
• 10Y*: -1.63%

ADMA

• 1D: 2.11%
• 1M: -24.73%
• YTD: -57.46%
• 6M: -60.65%
• 1Y: -62.07%
• 3Y*: 24.20%
• 5Y*: 34.85%
• 10Y*: 0.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NEXT vs. ADMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NEXT NextDecade Corporation	60.15%	-31.65%	61.64%	-3.44%	73.33%	36.36%	-65.96%	13.70%	-35.10%	-17.79%
ADMA ADMA Biologics, Inc.	-57.46%	6.36%	279.42%	16.49%	175.18%	-27.69%	-51.25%	67.36%	-25.55%	-37.30%

Correlation

The correlation between NEXT and ADMA is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.19
Correlation (10Y) Calculated over the trailing 10-year period	0.15
Correlation (All Time) Calculated using the full available price history since Jun 5, 2015	0.15

The correlation between NEXT and ADMA shifts across timeframes, from 0.05 (1 year) to 0.19 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NEXT : $2.24B ADMA : $1.86B
EPS NEXT : -$1.35 ADMA : $0.68
Total Revenue (TTM) NEXT : $0.00 ADMA : $509.86M
Gross Profit (TTM) NEXT : -$15.67M ADMA : $312.42M
EBITDA (TTM) NEXT : -$271.66M ADMA : $218.74M

Return for Risk

NEXT vs. ADMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEXT

NEXT Risk / Return Rank: 42
NEXT Sharpe Ratio Rank: 42
NEXT Sortino Ratio Rank: 42
NEXT Omega Ratio Rank: 42
NEXT Calmar Ratio Rank: 41
NEXT Martin Ratio Rank: 41

ADMA

ADMA Risk / Return Rank: 3
ADMA Sharpe Ratio Rank: 3
ADMA Sortino Ratio Rank: 3
ADMA Omega Ratio Rank: 3
ADMA Calmar Ratio Rank: 3
ADMA Martin Ratio Rank: 1

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEXT vs. ADMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NextDecade Corporation (NEXT) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NEXT	ADMA	Difference
Sharpe ratio: Return per unit of total volatility	0.04	-1.14	+1.18
Sortino ratio: Return per unit of downside risk	0.53	-1.82	+2.35
Omega ratio: Gain probability vs. loss probability	1.07	0.76	+0.31
Calmar ratio: Return relative to maximum drawdown	0.04	-0.95	+1.00
Martin ratio: Return relative to average drawdown	0.07	-1.89	+1.95
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NEXT vs. ADMA - Sharpe Ratio Comparison

The current NEXT Sharpe Ratio is 0.04, which is higher than the ADMA Sharpe Ratio of -1.14. The chart below compares the historical Sharpe Ratios of NEXT and ADMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NEXT	ADMA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.04	-1.14	+1.18
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.34	0.59	-0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.02	0.01	-0.02
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	-0.01	0.00

Drawdowns

NEXT vs. ADMA - Drawdown Comparison

The maximum NEXT drawdown since its inception was -88.79%, roughly equal to the maximum ADMA drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for NEXT and ADMA.

Drawdown Indicators

	NEXT	ADMA	Difference
Max Drawdown Largest peak-to-trough decline	-88.79%	-91.28%	+2.49%
Max Drawdown (1Y) Largest decline over 1 year	-60.00%	-65.25%	+5.25%
Max Drawdown (3Y) Largest decline over 3 years	-60.00%	-68.99%	+8.99%
Max Drawdown (5Y) Largest decline over 5 years	-62.23%	-68.99%	+6.76%
Max Drawdown (10Y) Largest decline over 10 years	-88.79%	-86.11%	-2.68%
Current Drawdown Current decline from peak	-29.67%	-68.34%	+38.67%
Average Drawdown Average peak-to-trough decline	-39.06%	-53.03%	+13.97%
Ulcer Index Depth and duration of drawdowns from previous peaks	40.76%	32.90%	+7.86%

Volatility

NEXT vs. ADMA - Volatility Comparison

The current volatility for NextDecade Corporation (NEXT) is 17.09%, while ADMA Biologics, Inc. (ADMA) has a volatility of 20.34%. This indicates that NEXT experiences smaller price fluctuations and is considered to be less risky than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NEXT	ADMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.09%	20.34%	-3.25%
Volatility (6M) Calculated over the trailing 6-month period	46.59%	45.37%	+1.22%
Volatility (1Y) Calculated over the trailing 1-year period	63.81%	54.66%	+9.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	83.18%	59.46%	+23.72%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	87.04%	69.03%	+18.01%

Dividends

NEXT vs. ADMA - Dividend Comparison

Neither NEXT nor ADMA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both NEXT and ADMA in my portfolio?

NEXT and ADMA have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NEXT or ADMA?

ADMA has higher volatility (20.34%) compared to NEXT (17.09%). In terms of maximum drawdown, NEXT dropped -88.79% vs ADMA's -91.28%.

Which has better risk-adjusted returns?

NEXT currently has the higher Sharpe Ratio (0.04 vs -1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.